Simplified one-pot 18F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity

Rationale: Conventional 18F-labeling methods that demand substrate pre-modification or lengthy radiosynthesis procedures have impeded the visualization and translation of numerous biomolecules, as biomarkers or ligands, using modern positron emission tomography techniques in vivo. Moreover, 18F-labeled biomolecules in high molar activity (Am) that are indispensable for sensitive imaging could be only achieved under strict labeling conditions. Methods: Herein, 18F-labeled fluorothiophosphate (FTP) synthons in high Am have been generated rapidly in situ in reaction solutions with < 5% water via nucleophilic substitution by wet [18F]F-, which required minimal processing from cyclotron target water. Results: Various 18F-labeled FTP synthons have been prepared in 30 sec at room temperature with high radiochemical yields > 75% (isolated, non-decay-corrected). FTP synthons with unsaturated hydrocarbon or activated ester group can conjugate with typical small molecules, peptides, proteins, and metallic nanoparticles. 337-517 GBq μmol-1 Am has been achieved for 18F-labeled c(RGDyK) peptide using an automatic module with 37-74 GBq initial activity. Conclusion: The combination of high 18F-fluorination efficiency of FTP synthons and following mild conjugation condition provides a universal simplified one-pot 18F-labeling method for broad unmodified biomolecular substrates.

[1]  R. Paton,et al.  [18F]Difluorocarbene for positron emission tomography , 2022, Nature.

[2]  Shanshan Huang,et al.  Photoacoustic molecular imaging-escorted adipose photodynamic–browning synergy for fighting obesity with virus-like complexes , 2021, Nature Nanotechnology.

[3]  M. Akrami,et al.  Recent progress in biomedical applications of RGD-Based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review. , 2019, Journal of biomedical materials research. Part A.

[4]  K. Jurkschat,et al.  Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  P. Bartenstein,et al.  First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  Liming Nie,et al.  Rapid one-step 18F-radiolabeling of biomolecules in aqueous media by organophosphine fluoride acceptors , 2019, Nature Communications.

[7]  Michael V. Green,et al.  One-pot synthesis and biodistribution of fluorine-18 labeled serum albumin for vascular imaging. , 2018, Nuclear medicine and biology.

[8]  Krishan Kumar 18F-AlF–Labeled Biomolecule Conjugates as Imaging Pharmaceuticals , 2018, The Journal of Nuclear Medicine.

[9]  B. Wängler,et al.  Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers. , 2017, Seminars in nuclear medicine.

[10]  A. Windhorst,et al.  Fluorine-18 labelled building blocks for PET tracer synthesis. , 2017, Chemical Society reviews.

[11]  G. Bormans,et al.  Al18F-Labeling Of Heat-Sensitive Biomolecules for Positron Emission Tomography Imaging , 2017, Theranostics.

[12]  Steven H. Liang,et al.  18F-Labeling of Sensitive Biomolecules for Positron Emission Tomography , 2017 .

[13]  Sean M. Preshlock,et al.  18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography , 2016 .

[14]  M. Zalutsky,et al.  Preclinical Evaluation of 18 F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by ImmunoPET , 2016 .

[15]  M. Wuest,et al.  Rerouting the metabolic pathway of (18)F-labeled peptides: the influence of prosthetic groups. , 2015, Bioconjugate chemistry.

[16]  Xiaoyuan Chen,et al.  Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes , 2014, Bioconjugate chemistry.

[17]  F. Wuest,et al.  18F-Labeled Peptides: The Future Is Bright , 2014, Molecules.

[18]  F. Bénard,et al.  An organotrifluoroborate for broadly applicable one-step 18F-labeling. , 2014, Angewandte Chemie.

[19]  P. Scott,et al.  Radiosyntheses using fluorine-18: the art and science of late stage fluorination. , 2014, Current topics in medicinal chemistry.

[20]  Ashutosh Kumar Singh,et al.  Prospects of Nano–Material in Breast Cancer Management , 2013, Pathology & Oncology Research.

[21]  N. Devoogdt,et al.  Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody. , 2013, Nuclear medicine and biology.

[22]  N. Devoogdt,et al.  Immuno-imaging using nanobodies. , 2011, Current opinion in biotechnology.

[23]  Xiaoyuan Chen,et al.  Automated radiochemical synthesis of [18F]FBEM: a thiol reactive synthon for radiofluorination of peptides and proteins. , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[24]  A. Luxen,et al.  Fully Automated Preparation and Conjugation of N-Succinimidyl 4-[18F]Fluorobenzoate ([18F]SFB) with RGD Peptide Using a GE FASTlab™ Synthesizer , 2011, Molecular Imaging and Biology.

[25]  D E Olberg,et al.  Labeling strategies of peptides with ¹⁸F for positron emission tomography. , 2010, Current topics in medicinal chemistry.

[26]  A. Cuthbertson,et al.  One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18. , 2010, Journal of medicinal chemistry.

[27]  F. Wuest,et al.  Systematic comparison of two novel, thiol-reactive prosthetic groups for 18F labeling of peptides and proteins with the acylation agent succinimidyl-4-[18F]fluorobenzoate ([18F]SFB) , 2008, Amino Acids.

[28]  K. Jurkschat,et al.  18F-labeling of peptides by means of an organosilicon-based fluoride acceptor. , 2006, Angewandte Chemie.

[29]  R. Weissleder Scaling down imaging: molecular mapping of cancer in mice , 2002, Nature Reviews Cancer.

[30]  M E Phelps,et al.  Positron emission tomography provides molecular imaging of biological processes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  W. Stec,et al.  Diastereomers of Nucleoside 3'-O-(2-Thio-1,3,2-oxathia(selena)phospholanes): Building Blocks for Stereocontrolled Synthesis of Oligo(nucleoside phosphorothioate)s , 1995 .

[32]  J. Pawelek,et al.  Phosphorylated isomers of L-dopa stimulate MSH binding capacity and responsiveness to MSH in cultured melanoma cells. , 1987, Biochemical and biophysical research communications.

[33]  J. Pawelek,et al.  Increase in melanin formation and promotion of cytotoxicity in cultured melanoma cells caused by phosphorylated isomers of L-dopa. , 1986, Cancer research.